Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine

2007 ◽  
Vol 42 (4) ◽  
pp. 735-745 ◽  
Author(s):  
Amber D. Moelker ◽  
Timo Baks ◽  
Kim M.A.M. Wever ◽  
Dimitry Spitskovsky ◽  
Piotr A. Wielopolski ◽  
...  
2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Foued Ghanjati ◽  
Simeon Santourlidis

The epigenetic mechanism of DNA methylation is of central importance for cellular differentiation processes. Unrestricted somatic stem cells (USSCs) from human umbilical cord blood, which have a broad differentiation spectrum, reside in an uncommitted epigenetic state with partial methylation of the regulatory region of the gene coding for the pluripotency master regulator OCT4. Thus we hypothesized that further opening of this “poised” epigenetic state could broaden the differentiation potential of USSCs. Here we document that USSCs drastically change their phenotype after treatment by a new elaborated cultivation protocol which utilizes the DNA hypomethylating compound 5′-aza-2-deoxycytidine (5-Aza-CdR) and the histone deacetylase inhibitor trichostatin A (TSA). This treatment leads to a new stable, spheroid-forming cell type which we have named SpheUSSC. These cells can be stably propagated over at least 150 cell divisions, express OCT4, retain the potential to undergo osteogenic differentiation, and have additionally acquired the ability to uniformly differentiate into adipocytes, unlike the source USSC population. Here we describe our treatment protocol and provide evidence that it induces a dedifferentiation step and concomitantly the acquisition of an extended differentiation capability of the new SpheUSSC type.


2008 ◽  
Vol 17 (2) ◽  
pp. 221-232 ◽  
Author(s):  
Susanne Greschat ◽  
Jessica Schira ◽  
Patrick Küry ◽  
Claudia Rosenbaum ◽  
Maria Angelica de Souza Silva ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1276-1276
Author(s):  
Shing Leng Chan ◽  
Michael S.K. Choi ◽  
Stephan Wnendt ◽  
Morey Kraus ◽  
Eileen Teng ◽  
...  

Abstract Mesenchymal stem cells have been implicated as playing an important role in stem cell engraftment. A new pluripotent population of umbilical cord blood (UCB)-derived Unrestricted Somatic Stem Cells (USSCs), with intrinsic and directable potential to develop into mesodermal, endodermal and ectodermal fates, has recently been identified and characterized (1). In this study we evaluated the capacity of USSCs to influence the homing of UCB -derived CD34+ cells into the marrow and spleen of NOD/SCID mice. Cultured USSCs were co-transplanted with CFDA-labeled cord blood CD34+ cells into sublethally irradiated NOD/SCID mice. Femurs and spleens were harvested 16 hrs thereafter and the percentage of CD34+ cells determined by flow cytometry. USSCs induced a significant enhancement of CD34+ cell homing to both bone marrow and spleen (2.2 ± 0.3 and 2.4 ± 0.6 -fold, respectively; p<0.05). Similar findings were obtained with frozen USSC samples that had been thawed prior to transplantation. The effect of USSCs was specific, as no homing enhancement could be observed by co-transplantation of CD34+ cells with lineage-positive UCB cells, which contain T, B and mature myelo-erythroid cells. Enhanced marrow homing by USSCs was unaltered by extensive culture passaging of the cells, with a similar degree of enhancement observed for both early (p5) and late (p10) passage USSCs (1.7 ± 0.1 and 1.9 ± 0.1 -fold, respectively). Enhanced homing was dose-dependent, detectable at USSC/CD34+ ratios of 1:1 and above. USSCs were also found to enhance the homing of day 14 cells harvested from cultures of selectively amplifiedTM, ex-vivo expanded UCB lineage-negative (lin-) cells. The relative proportion of homing CD34+ cells within the culture-expanded cell population, was unaffected by USSC co-transplantation. Our findings thus demonstrate that USSCs enhance the homing of UCB hematopoietic stem cells and suggest a clinical potential for these cells in facilitating engraftment under conditions of limiting cord blood stem cell numbers.


Sign in / Sign up

Export Citation Format

Share Document